JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
JVSAX
Price
$17.27
Change
-$0.18 (-1.03%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs JVSAX

Header iconJVMTX vs JVSAX Comparison
Open Charts JVMTX vs JVSAXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Janus Henderson Small-Mid Cap Value A
Price$17.27
Change-$0.18 (-1.03%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs JVSAX Comparison Chart
Loading...
VS
JVMTX vs. JVSAX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and JVSAX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.3B vs. JVSAX (106M). JVMTX pays higher dividends than JVSAX: JVMTX (0.73) vs JVSAX (0.61). JVMTX was incepted earlier than JVSAX: JVMTX (11 years) vs JVSAX (13 years). JVSAX is a more actively managed with annual turnover of: 62.00 vs. JVMTX (41.00). JVMTX has a lower initial minimum investment than JVSAX: JVMTX (0) vs JVSAX (2500). JVSAX annual gain was more profitable for investors over the last year : 37.42 vs. JVMTX (19.27). JVMTX return over 5 years is better than : 43.64 vs. JVSAX (32.94).
JVMTXJVSAXJVMTX / JVSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years13 years-
Gain YTD11.01020.84553%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets23.3B106M21,981%
Annual Yield % from dividends0.730.61119%
Returns for 1 year19.2737.4252%
Returns for 3 years13.3834.1839%
Returns for 5 years43.6432.94133%
Returns for 10 years63.3449.01129%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems